Disclosures for "Glioblastoma Multiforme Tumor Volume and Persistence of Chimeric Antigen Receptor T Cells Following Neurosurgical Debulking"
-
Miss Veerappan has nothing to disclose.
-
The institution of Dr. Thomas has received research support from NIH. The institution of Dr. Thomas has received research support from Health Resources & Services Administration. The institution of Dr. Thomas has received research support from California Institute of Regenerative Medicine. Dr. Thomas has received intellectual property interests from a discovery or technology relating to health care.